INNOGEN-B (02591) fell more than 9% today, after closing up over 32% in the previous trading session. As of the time of writing, the stock was down 9.1% to HK$15.18, with a turnover of HK$131 million.
According to a previous announcement from INNOGEN-B, the lock-up period for its cornerstone investors is set to expire on May 14, 2026, with the related shares becoming freely tradable starting May 15. The cornerstone investors collectively hold approximately 4.201 million shares.
INNOGEN-B's 2025 annual results showed that the group generated revenue of about RMB 131.5 million, primarily from sales of Isopagulide α in China. The net loss widened to RMB 341 million, an increase of 95.4% year-on-year.
Comments